Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. It is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
Domain
nuvalent.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$500.0M
Founded
2016
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Nuvalent use?+
Nuvalent uses 14 technologies including Google Analytics, Google Tag Manager, Microsoft Advertising.
What industry is Nuvalent in?+
Nuvalent operates in the Biotechnology industry.
Where is Nuvalent based?+
Nuvalent is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026